Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-05

FDA Approved: UPNEEQ — Supplemental Application (RVL Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for UPNEEQ (oxymetazoline hydrochloride ophthalmic solution) from RVL Pharmaceuticals, Inc., indicating changes to t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Upneeq (oxymetazoline)

Snippet

SUPPL AP for UPNEEQ (OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC)